Chaetocin antileukemia activity against chronic myelogenous leukemia cells is potentiated by bone marrow stromal factors and overcomes innate imatinib resistance.
about
Chaetocin induces apoptosis in human melanoma cells through the generation of reactive oxygen species and the intrinsic mitochondrial pathway, and exerts its anti-tumor activity in vivoAdipocytes cause leukemia cell resistance to daunorubicin via oxidative stress response.Reactive oxygen species in haematopoiesis: leukaemic cells take a walk on the wild side.
P2860
Chaetocin antileukemia activity against chronic myelogenous leukemia cells is potentiated by bone marrow stromal factors and overcomes innate imatinib resistance.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Chaetocin antileukemia activit ...... es innate imatinib resistance.
@en
type
label
Chaetocin antileukemia activit ...... es innate imatinib resistance.
@en
prefLabel
Chaetocin antileukemia activit ...... es innate imatinib resistance.
@en
P2093
P2860
P356
P1433
P1476
Chaetocin antileukemia activit ...... es innate imatinib resistance.
@en
P2093
C Hutchinson
J F DeCoteau
P2860
P2888
P356
10.1038/ONCSIS.2014.37
P577
2014-10-20T00:00:00Z
P5875
P6179
1045717105